Complex preparation of patients with recurrent implantation failure for the transfer of good quality embryos in ivf-et cycles
DOI:
https://doi.org/10.12775/JEHS.2024.63.019Keywords
infertility, recurrent implantation failure, preparation for embryo transfer, vaginal microbiota, desynchronosis, insufficiency of vitamin D, oxidative and nitrosative stress, endothelial dysfunction, complex preparation for IVF-ET, pregnancyAbstract
The purpose of the study is to evaluate the effectiveness of the proposed method of complex preparation of patients with RIF with the restoration of the profile of vaginal microbiota and the functions of the main systems of sanogenesis with the help of adjuvants before the next attempt to transfer vitrified / warmed embryos of good quality in segmented IVF-ET cycles. Material and methods. 68 women of reproductive age with infertility and RIF, who were repeatedly but unsuccessfully treated in IVF-ET cycles with transfer of good quality embryos, and 32 fertile control women were comprehensively examined. A method of preparing patients with RIF for IVF-ET was developed, which included extended profiling of the vaginal microbiome, combined use of oral and vaginal antibacterial drugs against the background of the use of enzyme agents and antibiotic-resistant probiotics, as well as progestogens, melatonin, vitamin D, adjuvants for the correction of oxidative, nitrosative stress and restoration of endothelial function. The patients of the group with RNI were divided into 2 groups: 35 women who were prepared for the next attempt of IVF-ET according to the proposed method, and 33 patients who received the standard method of preparation. The microbiological, laboratory and clinical results of the training were evaluated. The results. Improvement of the composition of the vaginal microbiota, hormonal, nitrosative and oxidative status, functional activity of the endothelium of patients with RIF according to the proposed method of preparation for IVF-ET led to an increase in the frequency of clinical pregnancy by 2.26 times (45.71% vs. 21.21 %; OR 3.1278 [95% CI 1.0759-9.0930], p<0.04) and termination of induced pregnancy by delivery 3.30 times (40.00 % vs. 12.12 %; OR 4.8333 [95% CI 1.3916-16.7870], p<0.02). Conclusions. The proposed complex method of preparing patients with RIF before IVF-ET is effective and can be recommended for use in clinical practice.
References
Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, et al. The International Glossary on Infertility and Fertility Care, 2017. Hum Reprod. 2017 Sep 1;32(9):1786-1801. doi: 10.1093/humrep/dex234.
ESHRE Working Group on Recurrent Implantation Failure; Cimadomo D, de Los Santos MJ, Griesinger G, Lainas G, Le Clef N, et al. ESHRE good practice recommendations on recurrent implantation failure. Hum Reprod Open. 2023 Jun 15;2023(3):hoad023. doi: 10.1093/hropen/hoad023.
Cimadomo D, Sosa Fernandez L, Soscia D, Fabozzi G, Benini F, Cesana A, et al. Inter-centre reliability in embryo grading across several IVF clinics is limited: implications for embryo selection. Reprod Biomed Online. 2022 Jan;44(1):39-48. doi: 10.1016/j.rbmo.2021.09.022.
Moreno I, Simon C. Deciphering the effect of reproductive tract microbiota on human reproduction. Reprod Med Biol. 2018 Nov 1;18(1):40-50. doi: 10.1002/rmb2.12249.
Moreno I, Garcia-Grau I, Perez-Villaroya D, Gonzalez-Monfort M, Bahçeci M, Barrionuevo MJ, et al. Endometrial microbiota composition is associated with reproductive outcome in infertile patients. Microbiome. 2022 Jan 4;10(1):1. doi: 10.1186/s40168-021-01184-w.
Koedooder R, Singer M, Schoenmakers S, Savelkoul PHM, Morré SA, de Jonge JD, et al. The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study. Hum Reprod. 2019 Jun 4;34(6):1042-1054. doi: 10.1093/humrep/dez065. Erratum in: Hum Reprod. 2019 Oct 2;34(10):2091-2092. doi: 10.1093/humrep/dez127.
Singer M, Borg M, Ouburg S, Morré SA. The relation of the vaginal microbiota to early pregnancy development during in vitro fertilization treatment-A meta-analysis. J Gynecol Obstet Hum Reprod. 2019 Apr;48(4):223-229. doi: 10.1016/j.jogoh.2019.01.007.
Lee YG, Lee D, Cha H, Ahn J, Koo HS, Hwang SY, et al. The therapeutic effects of vitamin D3 administration on the embryo implantation. Biomed Pharmacother. 2024 Jul;176:116853. doi: 10.1016/j.biopha.2024.116853.
Pustovalova LM Practical training in biochemistry. Rostov-on-Don: Phoenix, 1999. 541 p. [In Russian].
Gavrilov VB, Mishkorudnaya MI. Spectrophotometric determination of lipid hydroperoxides in blood plasma. Laboratory work. 1983;3:33-36. [In Russian].
Knight JA, Pieper RK, McClellan L. Specificity of the thiobarbituric acid reaction: its use in studies of lipid peroxidation. Clin Chem. 1988 Dec;34(12):2433-8. [In Russian].
Goryachkovsky AM. Clinical biochemistry: A reference manual. Odessa: Astroprint, 1998. 608 p. [In Russian].
Kovalevsky AN, Nifantiev O. Notes on the screening method for determining average-weight molecules. Laboratory work. 1989:5: 35-39. [In Russian].
Klebanov GI, Babenkova IV, Teselkin YuO, Omarov OS, Vladimirov YuA. Evaluation of antioxidant activity of blood plasma using yolk lipoproteins. Laboratory work. 1988;5:59-62. [In Russian].
Makarevich OP, Golikov PP. Superoxide dismutase activity in the acute period of various diseases. Laboratory work. 1983;6:24-27. [In Russian].
Korolyuk MA, Ivanova LI, Mayorova IG, Tokarev VE. Method for determination of catalase activity. Laboratory work. 1988;1:16-19. [In Russian].
Ermisch C, Markert UR. PIBF - Progesteron induzierter Blockierfaktor [PIBF - Progesterone-Induced Blocking Factor]. Z Geburtshilfe Neonatol. 2011 Jun;215(3):93-7. German. doi: 10.1055/s-0031-1271742.
Zhou M, Xu H, Zhang D, Si C, Zhou X, Zhao H, et al. Decreased PIBF1/IL6/p-STAT3 during the mid-secretory phase inhibits human endometrial stromal cell proliferation and decidualization. J Adv Res. 2020 Sep 9;30:15-25. doi: 10.1016/j.jare.2020.09.002.
Ghasemnejad-Berenji H, Ghaffari Novin M, Hajshafiha M, Nazarian H, Hashemi SM, Ilkhanizadeh B, et al. Immunomodulatory effects of hydroxychloroquine on Th1/Th2 balance in women with repeated implantation failure. Biomed Pharmacother. 2018 Nov;107:1277-1285. doi: 10.1016/j.biopha.2018.08.027.
Mahdian S, Zarrabi M, Moini A, Shahhoseini M, Movahedi M. In silico evidence for prednisone and progesterone efficacy in recurrent implantation failure treatment. J Mol Model. 2022 Mar 26;28(4):105. doi: 10.1007/s00894-022-05093-z. Erratum in: J Mol Model. 2023 May 23;29(6):184. doi: 10.1007/s00894-023-05576-7.
Liang PY, Diao LH, Huang CY, Lian RC, Chen X, Li GG, et al. The pro-inflammatory and anti-inflammatory cytokine profile in peripheral blood of women with recurrent implantation failure. Reprod Biomed Online. 2015 Dec;31(6):823-6. doi: 10.1016/j.rbmo.2015.08.009.
Luo G, Abrahams VM, Tadesse S, Funai EF, Hodgson EJ, Gao J, et al. Progesterone inhibits basal and TNF-alpha-induced apoptosis in fetal membranes: a novel mechanism to explain progesterone-mediated prevention of preterm birth. Reprod Sci. 2010 Jun;17(6):532-9. doi: 10.1177/1933719110363618.
Farahabadi A, Akbari M, Amini Pishva A, Zendedel A, Arabkheradmand A, Beyer C, et al. Effect of Progesterone Therapy on TNF-α and iNOS Gene Expression in Spinal Cord Injury Model. Acta Med Iran. 2016 Jun;54(6):345-51.
Su W, Gong C, Zhong H, Yang H, Chen Y, Wu X, et al. Vaginal and endometrial microbiome dysbiosis associated with adverse embryo transfer outcomes. Reprod Biol Endocrinol. 2024 Aug 28;22(1):111. doi: 10.1186/s12958-024-01274-y.
Aplin JD, Ruane PT. Embryo-epithelium interactions during implantation at a glance. J Cell Sci. 2017 Jan 1;130(1):15-22. doi: 10.1242/jcs.175943.
Diedrich K, Fauser BC, Devroey P, Griesinger G; Evian Annual Reproduction (EVAR) Workshop Group. The role of the endometrium and embryo in human implantation. Hum Reprod Update. 2007 Jul-Aug;13(4):365-77. doi: 10.1093/humupd/dmm011.
Dey SK, Lim H, Das SK, Reese J, Paria BC, Daikoku T, et al. Molecular cues to implantation. Endocr Rev. 2004 Jun;25(3):341-73. doi: 10.1210/er.2003-0020.
Kelleher AM, Milano-Foster J, Behura SK, Spencer TE. Uterine glands coordinate on-time embryo implantation and impact endometrial decidualization for pregnancy success. Nat Commun. 2018 Jun 22;9(1):2435. doi: 10.1038/s41467-018-04848-8.
Du H, Daftary GS, Lalwani SI, Taylor HS. Direct regulation of HOXA10 by 1,25-(OH)2D3 in human myelomonocytic cells and human endometrial stromal cells. Mol Endocrinol. 2005 Sep;19(9):2222-33. doi: 10.1210/me.2004-0336.
Jakubiec-Wisniewska K, Huras H, Kolak M. Effect of Vitamin D Supplementation on the Fetal Growth Rate in Pregnancy Complicated by Fetal Growth Restriction. Children (Basel). 2022 Apr 12;9(4):549. doi: 10.3390/children9040549.
Li D, Xu Y, Wang K, Yang Z, Li H, Lei S, et al. Maternal Vit D supplementation in AMA mice and the role of Vit D/VDR signaling in the offspring's cognition. Am J Transl Res. 2021 Nov 15;13(11):12650-12661.
von Websky K, Hasan AA, Reichetzeder C, Tsuprykov O, Hocher B. Impact of vitamin D on pregnancy-related disorders and on offspring outcome. J Steroid Biochem Mol Biol. 2018 Jun;180:51-64. doi: 10.1016/j.jsbmb.2017.11.008.
Hou H, Zhang JY, Chen D, Deng F, Morse AN, Qiu X, et al. Altered decidual and placental catabolism of vitamin D may contribute to the aetiology of spontaneous miscarriage. Placenta. 2020 Mar;92:1-8. doi: 10.1016/j.placenta.2020.01.013.
Ge X, Wang L, Li M, Xu N, Yu F, Yang F, et al. Vitamin D/VDR signaling inhibits LPS-induced IFNγ and IL-1β in Oral epithelia by regulating hypoxia-inducible factor-1α signaling pathway. Cell Commun Signal. 2019 Feb 27;17(1):18. doi: 10.1186/s12964-019-0331-9.
Wong MS, Leisegang MS, Kruse C, Vogel J, Schürmann C, Dehne N, et al. Vitamin D promotes vascular regeneration. Circulation. 2014 Sep 16;130(12):976-86. doi: 10.1161/CIRCULATIONAHA.114.010650.
Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet. 1997 Aug;16(4):391-6. doi: 10.1038/ng0897-391.
Begtrup LM, Specht IO, Hammer PEC, Flachs EM, Garde AH, Hansen J, et al. Night work and miscarriage: a Danish nationwide register-based cohort study. Occup Environ Med. 2019 May;76(5):302-308. doi: 10.1136/oemed-2018-105592.
Gómez-Acebo I, Dierssen-Sotos T, Papantoniou K, García-Unzueta MT, Santos-Benito MF, Llorca J. Association between exposure to rotating night shift versus day shift using levels of 6-sulfatoxymelatonin and cortisol and other sex hormones in women. Chronobiol Int. 2015 Feb;32(1):128-35. doi: 10.3109/07420528.2014.958494.
Li J, Bidlingmaier M, Petru R, Pedrosa Gil F, Loerbroks A, Angerer P. Impact of shift work on the diurnal cortisol rhythm: a one-year longitudinal study in junior physicians. J Occup Med Toxicol. 2018 Aug 14;13:23. doi: 10.1186/s12995-018-0204-y.
McCarthy R, Jungheim ES, Fay JC, Bates K, Herzog ED, England SK. Riding the Rhythm of Melatonin Through Pregnancy to Deliver on Time. Front Endocrinol (Lausanne). 2019 Sep 13;10:616. doi: 10.3389/fendo.2019.00616.
Sandyk R, Anastasiadis PG, Anninos PA, Tsagas N. The pineal gland and spontaneous abortions: implications for therapy with melatonin and magnetic field. Int J Neurosci. 1992 Feb;62(3-4):243-50. doi: 10.3109/00207459108999775.
Joseph TT, Schuch V, Hossack DJ, Chakraborty R, Johnson EL. Melatonin: the placental antioxidant and anti-inflammatory. Front Immunol. 2024 Feb 1;15:1339304. doi: 10.3389/fimmu.2024.1339304.
Voiculescu SE, Zygouropoulos N, Zahiu CD, Zagrean AM. Role of melatonin in embryo fetal development. J Med Life. 2014 Oct-Dec;7(4):488-92.
Olcese JM. Melatonin and Female Reproduction: An Expanding Universe. Front Endocrinol (Lausanne). 2020 Mar 6;11:85. doi: 10.3389/fendo.2020.00085.
Potapov VA. The feasibility of using L-arginine in the treatment of luteal phase insufficiency in patients of reproductive age. Health of Ukraine. Thematic number "Gynecology, Obstetrics, Reproduction". June 2016; 2 (22):55. [In Russian].
Vinogradova MA, Kirsanova TV, Serebriyskaya DS. Possibilities of optimizing preparation for pregnancy in the presence of conditions accompanied by endothelial dysfunction. Medical Council. 2020;(3):68–73. doi: 10.21518/2079-701X-2020-3-68-73. [In Russian].
Hoppensteadt DA, Fareed J. Pharmacological profile of sulodexide. Int Angiol. 2014 Jun;33(3):229-35.
Veraldi N, Guerrini M, Urso E, Risi G, Bertini S, Bensi D, Bisio A. Fine structural characterization of sulodexide. J Pharm Biomed Anal. 2018 Jul 15;156:67-79. doi: 10.1016/j.jpba.2018.04.012.
Cosmi B, Cini M, Legnani C, Pancani C, Calanni F, Coccheri S. Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a natural mixture of glycosaminoglycans. Thromb Res. 2003 Mar 15;109(5-6):333-9. doi: 10.1016/s0049-3848(03)00246-9.
Mauro M., Ferraro G., Palmieri G.C. Profibrinolytic and antithrombotic effects of sulodexide oral administration: a double-blind, cross-over, placebo-controlled study. Curr Ther Res. 1992;51:342–350.
Cerletti C, Rajtar G, Marchi E, De Gaetano G. Interaction between glycosaminoglycans, platelets, and leukocytes. Semin Thromb Hemost. 1994;20(3):245–253. doi: 10.1055/s-2007-1001909.
Ors Yildirim N, Yildirim AK, Demeli Ertus M, Dastan AO, Pehlivanoglu B, Chi YW, et al. Sulodexide Inhibits Arterial Contraction via the Endothelium-Dependent Nitric Oxide Pathway. J Clin Med. 2024 Apr 17;13(8):2332. doi: 10.3390/jcm13082332.
Young E. The anti-inflammatory effects of heparin and related compounds. Thromb Res. 2008;122(6):743-52. doi: 10.1016/j.thromres.2006.10.026.
Ligi D, Croce L, Mosti G, Raffetto JD, Mannello F. Chronic Venous Insufficiency: Transforming Growth Factor-β Isoforms and Soluble Endoglin Concentration in Different States of Wound Healing. Int J Mol Sci. 2017 Oct 21;18(10):2206. doi: 10.3390/ijms18102206.
Mannello F, Ligi D, Raffetto JD. Glycosaminoglycan sulodexide modulates inflammatory pathways in chronic venous disease. Int Angiol. 2014 Jun;33(3):236-42.Availale at: https://www.ncbi.nlm.nih.gov/pubmed/24936532.
Mannello F, Ligi D, Canale M, Raffetto JD. Sulodexide down-regulates the release of cytokines, chemokines, and leukocyte colony stimulating factors from human macrophages: role of glycosaminoglycans in inflammatory pathways of chronic venous disease. Curr Vasc Pharmacol. 2014 Jan;12(1):173-85. doi: 10.2174/1570161111666131126144025.
Ciszewicz M, Polubinska A, Antoniewicz A, Suminska-Jasinska K, Breborowicz A. Sulodexide suppresses inflammation in human endothelial cells and prevents glucose cytotoxicity. Transl Res. 2009 Mar;153(3):118-23. doi: 10.1016/j.trsl.2008.12.007.
Blich M, Golan A, Arvatz G, Sebbag A, Shafat I, Sabo E, et al. Macrophage activation by heparanase is mediated by TLR-2 and TLR-4 and associates with plaque progression. Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):e56-65. doi: 10.1161/ATVBAHA.112.254961.
Andreozzi GM. Role of sulodexide in the treatment of CVD. Int Angiol. 2014 Jun;33(3):255-62.
Mannello F, Medda V, Ligi D, Raffetto JD. Glycosaminoglycan sulodexide inhibition of MMP-9 gelatinase secretion and activity: possible pharmacological role against collagen degradation in vascular chronic diseases. Curr Vasc Pharmacol. 2013 May;11(3):354-65. doi: 10.2174/1570161111311030010.
Gil-Cardoso K, Del Bas JM, Caimari A, Lama C, Torres S, Mantecón L, et al. TetraSOD®, a Unique Marine Microalgae Ingredient, Promotes an Antioxidant and Anti-Inflammatory Status in a Metabolic Syndrome-Induced Model in Rats. Nutrients. 2022 Sep 28;14(19):4028. doi: 10.3390/nu14194028.
Ramirez P., Torres S., Lama C., Mantecón L., Unamunzaga C., Infante C. TetraSOD® activates the antioxidant response pathway in human cells: An in vitro approach. Afr. J. Biotechnol. 2020;19:367–373. doi: 10.5897/AJB2020.17163.
Rodríguez RM, Colom-Pellicer M, Blanco J, Calvo E, Aragonès G, Mulero M. Grape-Seed Procyanidin Extract (GSPE) Seasonal-Dependent Modulation of Glucose and Lipid Metabolism in the Liver of Healthy F344 Rats. Biomolecules. 2022 Jun 17;12(6):839. doi: 10.3390/biom12060839.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 O. Nosenko, R. Demidchik
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 135
Number of citations: 0
